Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 5/20 | 0.44 |
| ▸ | CA1 | P00915 | 4/20 | 0.44 |
| ▸ | CA7 | P43166 | 3/20 | 0.44 |
| ▸ | CA9 | Q16790 | 3/20 | 0.44 |
| ▸ | CA12 | O43570 | 2/20 | 0.44 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.44 |
| ▸ | CA4 | P22748 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.40 |
| ▸ | TP53 | P04637 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | HPGD | P15428 | 2/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3438872 | 0.86 | CA1 (0.52) | CA2CA1CA7CA9CA12 | |
| SCHEMBL14112614 | 0.86 | AR (0.42) | CA2CA1CA7CA9CA12 | |
| SCHEMBL28905579 | 0.84 | CA2 (0.44) | CA2ALDH1A1KDM4EMAPTALOX12 | |
| SCHEMBL4336477 | 0.81 | CA2 (0.41) | CA2ALDH1A1KDM4EMAPTALOX12 | |
| SCHEMBL28426083 | 0.81 | CA2 (0.41) | CA2ALDH1A1KDM4EMAPTALOX12 | |
| SCHEMBL28427116 | 0.80 | CA2 (0.38) | CA2ALDH1A1HSD17B10GABRA1GABRB2 | |
| SCHEMBL142899 | 0.79 | CA2 (0.57) | CA2CA1CA7CA9CA12 | |
| SCHEMBL29771456 | 0.79 | CA2 (0.57) | CA2CA1CA7CA9CA12 | |
| SCHEMBL303584 | 0.79 | CA2 (0.40) | CA2ALDH1A1TP53KDM4EMAPT | |
| SCHEMBL1889316 | 0.79 | CA2 (0.40) | CA2ALDH1A1TP53KDM4EMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108815174-A | A kind of modified form fat-soluble compositions and preparation method thereof | 昆山普瑞凯纳米技术有限公司 | 2018-11-16 | — | — | CN | disclosed |
| CN-207898025-U | Combination vamp and outsole for footwear product | 耐克创新有限合伙公司 | 2018-09-25 | — | — | CN | disclosed |
| CN-108056532-A | Knitted textile and shoe upper and manufacturing method thereof | 耐克创新有限合伙公司 | 2018-05-22 | — | — | CN | disclosed |
| EP-3221436-A1 | METHOD FOR PRODUCING CATIONIC SURFACTANT | Kao Corporation (JP) | 2017-09-27 | — | — | EP | disclosed |
| WO-2016080194-A1 | METHOD FOR PRODUCING CATIONIC SURFACTANT | KAO CORPORATION (JP) | 2016-05-26 | — | — | WO | disclosed |
| EP-2490291-B1 | LITHIUM SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR USE IN THE LITHIUM SECONDARY BATTERY | UBE INDUSTRIES (JP) | 2014-12-03 | — | — | EP | disclosed |
| EP-2490291-A1 | LITHIUM SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR USE IN THE LITHIUM SECONDARY BATTERY | Ube Industries, Ltd. (JP) | 2012-08-22 | — | — | EP | disclosed |
| US-20120183846-A1 | LITHIUM SECONDARY BATTERY, AND NON-AQUEOUS ELECTROLYTIC SOLUTION FOR USE IN THE LITHIUM SECONDARY BATTERY | UBE INDUSTRIES, LTD. (JP) | 2012-07-19 | — | — | US | disclosed |
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | OXFORD GENE TECHNOLOGY IP LIMITED (GB) | 2009-01-22 | — | — | US | disclosed |
| EP-0530861-B1 | Topical antimicrobial pharmaceutical compositions | KABARA JON JOSEPH (US) | 1998-09-09 | — | — | EP | disclosed |
| EP-0243145-B1 | TOPICAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS | Kabara, Jon Joseph (US) | 1993-07-14 | — | — | EP | disclosed |
| US-5208257-A | Treatment of skin parasites or microorganisms with glycerol monoester of lauric acid and fatty acids and carriers | KABARA JON J (US) | 1993-05-04 | — | — | US | disclosed |
| EP-0530861-A2 | Topical antimicrobial pharmaceutical compositions | Kabara, Jon Joseph (US) | 1993-03-10 | — | — | EP | disclosed |
| EP-0244144-A1 | Antimicrobial preservative compositions | Kabara, Jon Joseph (US) | 1987-11-04 | — | — | EP | disclosed |
| EP-0243145-A2 | Topical antimicrobial pharmaceutical compositions | Kabara, Jon Joseph (US) | 1987-10-28 | — | — | EP | disclosed |
| US-4375566-A | Process for producing ortho-alkylated phenols from anisoles | MITSUI TOATSU CHEMICALS, INC. (JP) | 1983-03-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023926-A1 | Trityl Derivatives for Enhancing Mass Spectrometry | F3, TBCA, GYPA | CA2 592/4885CA1 2113/4885CA7 551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.